Global Digital Pathology Market
Description
Global Digital Pathology Market
Global Digital Pathology Market By Product (Scanners, Software, Storage and Communication Systems), By End User (Educational, Clinical, Pharma & Biotech Companies), By Application (Teleconsultation, Disease Diagnosis, Drug Discovery, Training & Education) And By Geography – Covid-19 Impact Analysis, Post Covid Analysis, Opportunities, Trends And Forecast From 2020 to 2033
The global Digital Pathology market was valued at $956.3 Million in 2023 and is anticipated to grow at a CAGR of 9.81% from 2024 to 2034. This growth is attributed to several macro and microeconomic factors such as
Increase in prevalence of cancer
The surge in cancer prevalence stands as a pivotal driving force behind the rapid expansion of the Digital Pathology Market. With cancer emerging as a pervasive global health challenge, characterized by a continuous rise in new cases, there is an escalating need for advanced diagnostic and treatment approaches. Digital pathology, epitomized by the digitization of traditional tissue slides, offers a transformative solution. By harnessing computer technology, it empowers pathologists with enhanced diagnostic capabilities and streamlined workflow efficiencies. This digitized approach facilitates expedited and precise cancer diagnoses, crucial for prompt treatment planning and improved patient outcomes. Moreover, the advent of digital pathology transcends geographical boundaries, enabling remote consultation and collaboration among pathologists and specialists worldwide. This seamless exchange of expertise fosters multidisciplinary approaches to cancer care, further elevating diagnostic accuracy and patient management standards. Additionally, the integration of digital pathology with other healthcare technologies, such as electronic health records and laboratory information systems, enhances the overall diagnostic ecosystem. In essence, the escalating prevalence of cancer underscores the indispensable role of digital pathology in modern healthcare. As healthcare systems grapple with the burgeoning burden of cancer, the adoption of digital pathology solutions emerges as a cornerstone strategy in the quest for enhanced diagnostic precision, operational efficiency, and ultimately, improved patient outcomes.
Further several factors restraining the market growth include
High cost associated with digital pathology
The substantial financial commitment required for healthcare institutions to adopt and integrate digital pathology solution is expected to pose challenge to market growth. This cost encompasses various components, from the initial investment in hardware and software procurement to ongoing expenses for training, maintenance, and regulatory compliance. The significant upfront capital required for equipment acquisition, software development, and infrastructure setup can be particularly daunting for organizations with limited financial resources. Additionally, ongoing expenses for training programs, software updates, and technical support further compound the financial burden. Consequently, smaller healthcare facilities and practices may find it challenging to justify the investment in digital pathology, limiting market penetration. Despite these challenges, technological advancements and increasing competition among vendors are gradually driving down costs, making digital pathology more accessible. Furthermore, the long-term benefits of improved diagnostic accuracy, operational efficiency, and enhanced patient care outcomes may ultimately outweigh the initial investment, motivating healthcare organizations to overcome cost barriers and embrace digital pathology solutions.
Rapid technological advancements and collaborations and alliances in the Digital Pathology market are expected to generate higher avenues during the forecast period.
In the wake of the COVID-19 pandemic, supply chain disruptions have led to supply shortages or lower demand in the Digital Pathology market. The pandemic has caused a decline in new orders and a corresponding decrease in End Userion.
This section will analyze how COVID-19 has impacted supply chains, leading to shortages and lower demand for Digital Pathology.
In terms of COVID-19 impact, the Digital Pathology market report also includes the following data points:
Impact on Digital Pathology market size
Operating Weights Trend, Preferences, and Budget Impact
Regulatory Framework/Outdoor Policies
Key Players' Strategy to Tackle Negative Impact/Post-COVID Strategies
Opportunity in the Digital Pathology market
Key Insight in the report:
The global Digital Pathology market report covers an executive summary, market dynamics, COVID impact & post-COVID scenario, market size and forecast, competitive intelligence, market positioning, and End Users.
Our report covers extensive competitive intelligence which includes the following data points:
Business Overview
Business Segment Data
Financial Data
End User Segment Analysis and Specification
Recent Development and Company Strategy Analysis
SWOT Analysis
Digital Pathology Market Segmentation:
Product
Scanners
Software
Storage and Communication Systems
End User
Educational
Clinical
Pharma & Biotech Companies
Application
Teleconsultation
Disease Diagnosis
Drug Discovery
Training & Education
Region/ Countries Covered:
North America
US
Canada
Mexico
Europe
U.K.
Germany
France
Italy
Spain
BeNeLux
Russia
Rest of Europe
Asia Pacific
China
Japan
Australia
India
South Korea
Thailand
Indonesia
Malaysia
Rest of Asia Pacific
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
UAE
Egypt
South Africa
Rest of Middle East & Africa
Key Players Analyzed in the Report:
Leica Biosystems Nussloch GmbH
Hamamatsu Photonics Inc.
Koninklijke Philips N.V
Olympus Corporation
Hoffmann-La Roche Ltd
Mikroscan Technologies Inc.
Inspirata, Inc.
Epredia (3DHISTECH Ltd.)
Visiopharm A/S
Huron Technologies International Inc.
Table of Contents
110 Pages
- CHAPTER 1. Executive Summary
- CHAPTER 2. Scope of the Study
- 2.1. Market Definition
- 2.2. Market Scope & Segmentation
- 2.2.1. Objective of Report
- CHAPTER 3. Evolve BI Methodology
- 3.1. Data Collection & Validation Approach
- 3.2. Market Size Estimation and Forecast
- CHAPTER 4. Market Insights and Trends
- 4.1. Value Chain Analysis
- 4.1.1. Raw Materials
- 4.1.2. Manufacturing
- 4.1.3. Distribution Channel
- 4.1.4. End User
- 4.2. Porter’s Five Forces Analysis
- 4.2.1. Bargaining Power of Buyers
- 4.2.2. Bargaining Power of Suppliers
- 4.2.3. Threat of New Entrant
- 4.2.4. Threat of Substitute
- 4.2.5. Industry Rivalry
- 4.3. COVID-19 Impact and Post-COVID Scenario on Digital Pathology Market
- 4.3.1. Impact of COVID-19
- 4.3.2. Government Support and Industry Revival Policies
- 4.3.3. Post COVID Trend
- CHAPTER 5. Market Dynamics
- 5.1. Introduction
- 5.2. Drivers
- 5.2.1. Increase in prevalence of cancer
- 5.2.2. Rise in the demand for accurate diagnostics
- 5.3. Restraints
- 5.3.1. High cost associated with digital pathology systems
- 5.4. Opportunity
- 5.4.1. Rapid technological advancements in digital pathology systems
- CHAPTER 6. Global Digital Pathology Market, By Product
- 6.1. Introduction
- 6.1.1. Scanners
- 6.1.2. Software
- 6.1.3. Storage and Communication Systems
- CHAPTER 7. Global Digital Pathology Market, By End User
- 7.1. Introduction
- 7.1.1. Educational
- 7.1.2. Clinical
- 7.1.3. Pharma & Biotech Companies
- CHAPTER 8. Global Digital Pathology Market, By Application
- 8.1. Introduction
- 8.1.1. Teleconsultation
- 8.1.2. Disease Diagnosis
- 8.1.3. Drug Discovery
- 8.1.4. Training & Education
- CHAPTER 9. Global Digital Pathology Market, By Region
- 9.1. Introduction
- 9.2. North America
- 9.2.1. North America: Market Size and Forecast, By Country, 2021 – 2034 ($ Million)
- 9.2.2. North America: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.2.3. North America: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.2.4. North America: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.2.5. US
- 9.2.5.1. US: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.2.5.2. US: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.2.5.3. US: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.2.6. Canada
- 9.2.6.1. Canada: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.2.6.2. Canada: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.2.6.3. Canada: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.2.7. Mexico
- 9.2.7.1. Mexico: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.2.7.2. Mexico: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.2.7.3. Mexico: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.3. Europe
- 9.3.1. Europe: Market Size and Forecast, By Country, 2021 – 2034 ($ Million)
- 9.3.2. Europe: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.3.3. Europe: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.3.4. Europe: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.3.5. U.K.
- 9.3.5.1. U.K.: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.3.5.2. U.K.: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.3.5.3. U.K.: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.3.6. Germany
- 9.3.6.1. Germany: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.3.6.2. Germany: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.3.6.3. Germany: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.3.7. France
- 9.3.7.1. France: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.3.7.2. France: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.3.7.3. France: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.3.8. Italy
- 9.3.8.1. Italy: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.3.8.2. Italy: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.3.8.3. Italy: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.3.9. Spain
- 9.3.9.1. Spain: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.3.9.2. Spain: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.3.9.3. Spain: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.3.10. BeNeLux
- 9.3.10.1. BeNeLux: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.3.10.2. BeNeLux: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.3.10.3. BeNeLux: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.3.11. Russia
- 9.3.11.1. Russia: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.3.11.2. Russia: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.3.11.3. Russia: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.3.12. Rest of Europe
- 9.3.12.1. Rest of Europe: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.3.12.2. Rest of Europe: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.3.12.3. Rest of Europe: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.4. Asia Pacific
- 9.4.1. Asia Pacific: Market Size and Forecast, By Country, 2021 – 2034 ($ Million)
- 9.4.2. Asia Pacific: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.4.3. Asia Pacific: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.4.4. Asia Pacific: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.4.5. China
- 9.4.5.1. China: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.4.5.2. China: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.4.5.3. China: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.4.6. Japan
- 9.4.6.1. Japan: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.4.6.2. Japan: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.4.6.3. Japan: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.4.7. Australia
- 9.4.7.1. Australia: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.4.7.2. Australia: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.4.7.3. Australia: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.4.8. India
- 9.4.8.1. India: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.4.8.2. India: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.4.8.3. India: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.4.9. South Korea
- 9.4.9.1. South Korea: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.4.9.2. South Korea: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.4.9.3. South Korea: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.4.10. Malaysia
- 9.4.10.1. Malaysia: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.4.10.2. Malaysia: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.4.10.3. Malaysia: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.4.11. Thailand
- 9.4.11.1. Thailand: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.4.11.2. Thailand: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.4.11.3. Thailand: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.4.12. Indonesia
- 9.4.12.1. Indonesia: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.4.12.2. Indonesia: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.4.12.3. Indonesia: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.4.13. Rest of Asia Pacific
- 9.4.13.1. Rest of Asia Pacific: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.4.13.2. Rest of Asia Pacific: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.4.13.3. Rest of Asia Pacific: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.5. South America
- 9.5.1. South America: Market Size and Forecast, By Country, 2021 – 2034 ($ Million)
- 9.5.2. South America: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.5.3. South America: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.5.4. South America: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.5.5. Brazil
- 9.5.5.1. Brazil: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.5.5.2. Brazil: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.5.5.3. Brazil: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.5.6. Argentina
- 9.5.6.1. Argentina: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.5.6.2. Argentina: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.5.6.3. Argentina: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.5.7. Rest of South America
- 9.5.7.1. Rest of South America: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.5.7.2. Rest of South America: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.5.7.3. Rest of South America: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.6. Middle East & Africa
- 9.6.1. Middle East & Africa: Market Size and Forecast, By Country, 2021 – 2034 ($ Million)
- 9.6.2. Middle East & Africa: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.6.3. Middle East & Africa: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.6.4. Middle East & Africa: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.6.5. Saudi Arabia
- 9.6.5.1. Saudi Arabia: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.6.5.2. Saudi Arabia: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.6.5.3. Saudi Arabia: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.6.6. UAE
- 9.6.6.1. UAE: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.6.6.2. UAE: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.6.6.3. UAE: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.6.7. Egypt
- 9.6.7.1. Egypt: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.6.7.2. Egypt: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.6.7.3. Egypt: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.6.8. South Africa
- 9.6.8.1. South Africa: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.6.8.2. South Africa: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.6.8.3. South Africa: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- 9.6.9. Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
- 9.6.9.2. Rest of Middle East & Africa: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
- 9.6.9.3. Rest of Middle East & Africa: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
- CHAPTER 10. Competitive Landscape
- 10.1. Competitior Benchmarking 2023
- 10.2. Market Share Analysis, 2023
- 10.3. Key Developments Analysis By Top 5 Companies
- 10.4. Market Share Acquisition Strategies: Analysis of Key Approaches Employed by Top Players
- CHAPTER 11. Company Profiles
- 11.1. Leica Biosystems Nussloch GmbH
- 11.1.1. Business Overview
- 11.1.2. Financial Analysis
- 11.1.2.1. Business Segment Revenue, 2023
- 11.1.2.2. Geographic Revenue Mix, 2023
- 11.1.3. Product Portfolio
- 11.1.4. Recent Development and Strategies Adopted
- 11.1.5. SWOT Analysis
- 11.2. Hamamatsu Photonics Inc.
- 11.2.1. Business Overview
- 11.2.2. Financial Analysis
- 11.2.2.1. Business Segment Revenue, 2023, (% Share)
- 11.2.2.2. Geographic Revenue Mix, 2023
- 11.2.3. Product Portfolio
- 11.2.4. Recent Development and Strategies Adopted
- 11.2.5. SWOT Analysis
- 11.3. Koninklijke Philips N.V
- 11.3.1. Business Overview
- 11.3.2. Financial Analysis
- 11.3.2.1. Business Segment Revenue, 2023
- 11.3.2.2. Geographic Revenue Mix, 2023
- 11.3.3. Product Portfolio
- 11.3.4. Recent Development and Strategies Adopted
- 11.3.5. SWOT Analysis
- 11.4. Olympus Corporation
- 11.4.1. Business Overview
- 11.4.2. Financial Analysis
- 11.4.2.1. Business Segment Revenue, 2023
- 11.4.2.2. Geographic Revenue Mix, 2023
- 11.4.3. Product Portfolio
- 11.4.4. Recent Development and Strategies Adopted
- 11.4.5. SWOT Analysis
- 11.5. Hoffmann-La Roche Ltd
- 11.5.1. Business Overview
- 11.5.2. Financial Analysis
- 11.5.2.1. Business Segment Revenue, 2023
- 11.5.3. Product Portfolio
- 11.5.4. Recent Development and Strategies Adopted
- 11.5.5. SWOT Analysis
- 11.6. Mikroscan Technologies Inc
- 11.6.1. Business Overview
- 11.6.2. Product Portfolio
- 11.6.3. Recent Development and Strategies Adopted
- 11.7. Inspirata, Inc
- 11.7.1. Business Overview
- 11.7.2. Product Portfolio
- 11.7.3. Recent Development and Strategies Adopted
- 11.8. Epredia (3DHISTECH Ltd.)
- 11.8.1. Business Overview
- 11.8.2. Product Portfolio
- 11.8.3. Recent Development and Strategies Adopted
- 11.9. Visiopharm A/S
- 11.9.1. Business Overview
- 11.9.2. Product Portfolio
- 11.9.3. Recent Development and Strategies Adopted
- 11.10. Huron Technologies International Inc
- 11.10.1. Business Overview
- 11.10.2. Product Portfolio
- 11.10.3. Recent Development and Strategies Adopted
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
